Our Team

Executive Management

Cameron Rouns

Chief Executive Officer

Mr. Rouns brings over 25 years of experience delivering market transforming technologies to the medical industry.  He has a strong history of leveraging disruptive innovation that has displaced market leaders and propelled businesses to dominant market positions; many crossing the billion dollar revenue threshold.  His experience spans organizations ranging from pre-revenue startups to Fortune 100 companies (Kimberly-Clark, Medtronic, Abbott, Amedica, Enviro H20 Labs).  Cameron received his MBA from the W.L.Gore School of Business at Westminster College and holds a B.S. in Chemistry from Idaho State University.

Tim Way

Finance & Administration

Mr. Way has over 30 years of finance, corporate strategy, and broad operational experience including co-founding a medical device company; Cardiotronics, which was sold to Ballard Medical Products/Kimberly-Clark.  Tim has led a wide range of strategic financing activities across medical devices, managed care, software and contract manufacturing segments (Cardiac Science, Cardiotronics, Stafford Health Systems).  Tim received his B.S. in Finance from San Diego State University and a Certificate in Accounting from the University of Washington.

Kok-Hwee Ng, Ph.D.

Research & Development

Dr. Ng combines a passion for emerging technology with over two decades of leadership and management experience in the medical device industry. He is a MedTech architect whose creations have been motivated by customer value, and influenced by experiences in product engineering and scientific discoveries. His unique skill set comes with a track record at both start-ups and Fortune 500 companies (Orthosensor, St. Jude Medical, Stryker, Boston Scientific, Johnson & Johnson, Baxter International, General Electric Medical Systems). Kok-Hwee received his Ph.D in Biomedical Engineering and M.S. in Electrical Engineering from the McCormick School of Engineering at Northwestern University. He also holds a B.S. in Electrical Engineering from the National University of Singapore.

Erin Manning

Vice President, Marketing

Ms. Manning is an experienced marketer with a background in both the consumer and healthcare sectors (Johnson & Johnson, Abbott, Deckers). She has a track record for delivering accelerated growth for both established brands and new product introductions. Her medical device marketing experience spans capital equipment, consumables and implantable devices. She has held roles in strategic marketing, product management, commercial operations and field sales. Ms. Manning holds an MBA from the Paul Merage School of Business at University of California, Irvine and a B.A. in English from University of California, Santa Barbara.

Brian Caulfield

Operations

Mr. Caulfield brings broad-based expertise in strategic and operational leadership across a range of manufacturing technologies in Coronary, Endovascular, Peripheral and Neurovascular implantable and catheter based products. He has led corporate initiatives for insourcing and outsourcing in both startups and Fortune 500 companies (Medtronic, Endologix, Terumo, Trivascular). Brian received his MBA from the Ross School of Business at the University of Michigan along with both a Masters and Bachelors degrees in Biomedical Engineering from National University of Ireland.

Adrian Ponce, Ph.D.

Founder & Chief Science Officer

Founder and Chief Science Officer for Verrix, Dr. Ponce has an extensive resume of research and development accomplishments including patents, publications and successful NASA development initiatives. Adrian received his Doctorate in Chemistry from Caltech which led him to join an exclusive team at Jet Propulsion Laboratory that continues to develop new to world technologies.

Aiying Sun

Regulatory & Quality

Ms. Sun brings extensive expertise in Quality Assurance and Regulatory Affairs from over 25 years of experience working for medical device and pharmaceutical companies including Siemens Healthcare, Alcon (Novartis), Masimo, Watson (Activis), and B Braun Medical. She has worked closely with the U.S. FDA and many international regulatory authorities and has established and continuously improved Quality Management Systems for medical device companies to ensure compliance with applicable regulations and standards. Aiying received her MBA from the Anderson School of Business at the University of California, Los Angeles. She also holds an M.S. in Bioengineering from University of Toledo (Ohio) and a B.S. degree in Biochemical Engineering from Beijing University of Chemical Technology.

Board of Directors

Sami El-Saden

Chairman of the Board

Mr. El-Saden most recently served as President & CEO of Ignite USA, the North American market leader in environmentally safe reusable beverage containers. He transformed it from an industrial design firm into one of the fastest growing consumer product companies in the U.S. with over $300 million in sales. He sold the business to Newell Brands, one of the leading consumer goods companies in the world with over $16 billion in sales. Prior to Ignite, he held senior marketing and business development positions at Nestle USA, Favorite Brands International and EthnicGrocer.com, an internet start-up funded by Kleiner Perkins, Benchmark Capital and others. Sami spent his early career as an investment banker in corporate finance at Smith Barney, Harris Upham and Banker’s Trust Company. Mr. El-Saden received his MBA from the John E. Anderson Graduate School of Management at UCLA and graduated with distinction in 1984 from Stanford University with a B.A. in Economics.

Leon Alkalai Ph.D.

Director & Co-Founder

Dr. Alkalai received his Ph.D. in Computer Science from UCLA in 1989. Since then, he has worked at JPL in various leadership positions. He is the Assistant Division Manager and the Lead for Formulation at JPL’s Engineering and Science Directorate. Dr. Alkalai was the JPL formulation lead for both the GRAIL mission to the Moon (awarded in 2007 and launched in 2011) and the InSight mission to Mars. Dr. Alkalai is a JPL Fellow and a Full Member of the International Academy of Astronautics (IAA). In 2012, he received the NASA Individual Distinguished Achievement Medal for his contribution to winning the 2007 NASA Discovery competition.

John Buhler

Independent Director

Mr. Buhler has extensive experience in the technology, life-sciences and healthcare fields with a career spanning 30+ years. He has been the CEO/COO of three public and three private companies, completed numerous rounds of financing, done ~$1bb in M&A, and most recently merged RF Surgical Systems, Inc. with Medtronic. He has successfully completed four turnarounds, with each entity becoming a high growth/profitable business in its discipline. Mr. Buhler has an impressive history generating new revenue streams, building business, and increasing market share for multi-million and multi-billion dollar international high-technology corporations. His businesses have demonstrated the ability to penetrate new markets and strengthen competitive positioning, design and direct high-impact strategic plans, define visions and transform concepts into lucrative workable realities.

Adrian Ponce, Ph.D.

Director, Co-Founder & Chief Science Officer

Founder and Chief Science Officer for Verrix, Dr. Ponce has an extensive resume of research and development accomplishments including patents, publications and successful NASA development initiatives. Adrian received his Doctorate in Chemistry from Caltech which led him to join an exclusive team at Jet Propulsion Laboratory that continues to develop new to world technologies.

Cameron Rouns

Director & Chief Executive Officer

Mr. Rouns brings over 25 years of experience delivering market transforming technologies to the medical industry.  He has a strong history of leveraging disruptive innovation that has displaced market leaders and propelled businesses to dominant market positions; many crossing the billion dollar revenue threshold.  His experience spans organizations ranging from pre-revenue startups to Fortune 100 companies (Kimberly-Clark, Medtronic, Abbott, Amedica, Enviro H20 Labs).  Cameron received his MBA from the W.L.Gore School of Business at Westminster College and holds a B.S. in Chemistry from Idaho State University.

Scientific Advisory Board

Sigal Ben-Yahuda, Ph.D.

Sigal Ben-Yehuda obtained her PhD at the Department of Molecular Microbiology and Biotechnology of the Tel-Aviv University, Israel and subsequently carried out post-doctoral research on the sporulation of Bacillus subtilis in the laboratory of Professor Richard Losick at the Department of Molecular and Cellular Biology of Harvard University, USA. She is currently an Associate Professor in the Department of Microbiology and Molecular Genetics at the Institute for Medical Research, Israel-Canada (IMRIC) in the faculty of Medicine of The Hebrew University of Jerusalem. Her research focusses on understanding the process of bacterial cell division. She has received many academic awards including The Sir Zelman Cowen Prize for discovery in medical research (2011) the ISM (Israel society for microbiology)-Shilo Award (2011) and the Hebrew University President’s Award (Ben-Porat) for excellence in research (2007).

Scott E. Fraser, Ph.D.

Professor Scott E. Fraser has a long-standing commitment to quantitative biology, applying the tools of chemistry, engineering, and physics to problems in biology and medicine. His personal research centers on imaging and molecular analyses of intact biological systems, with an emphasis on early development, organogenesis, and medical diagnostics.  In Fall 2012, he moved to USC to take a Provost Professorship in the Dornsife College of Letters Arts and Sciences, the Children’s Hospital Los Angeles, Keck School of Medicine and the Viterbi School of Engineering. He remains active in interdisciplinary research and serves as the Director of Science Initiatives for the USC campuses.

Harry B. Gray, Ph.D.

Dr. Gray received his B.S. in Chemistry from Western Kentucky University in 1957. He began his work in inorganic chemistry at Northwestern University, where he earned his Ph.D. in 1960 working under Fred Basolo and Ralph Pearson. He was initiated into the Upsilon chapter of Alpha Chi Sigma at Northwestern University in 1958. After completing his NSF Postdoctoral Fellow at the University of Copenhagen, he went to New York to take up a faculty appointment at Columbia University. In 1966, he moved to the California Institute of Technology, where he became the Arnold O. Beckman Professor of Chemistry and founding director of the Beckman Institute.

Aaron Noell, Ph.D.

Dr. Noell a scientist at JPL and developing instruments for the assessment of habitability and the search for extant life on other bodies in the solar system. His instrument development has focused on microfluidic implementation of capillary electrophoresis, ion chromatography, and selective electrochemical detection (e.g., ion selective electrodes). Additionally, he has worked to develop sample handling and extraction techniques compatible with microfluidic instruments, such as subcritical water extraction. Previously, he was an NPP Postdoc at JPL working on instrumentation to detect bacterial spores for both biodefense and astrobiology purposes, and received his Ph.D. in Chemistry from Caltech in 2010.

Jay Winkler, Ph.D.

Jay R. Winkler is a Faculty Associate in the Division of Chemistry and Chemical Engineering at the California Institute of Technology (Caltech), a Member of the Beckman Institute at Caltech, and Director of the Beckman Institute Laser Resource Center. Winkler has a B.S. in Chemistry from Stanford University, and Ph.D. in Chemistry from Caltech. He has authored more than 230 research publications spanning a range of disciplines including: inorganic, organometallic, and bioinorganic chemistry; steady-state and time-resolved laser spectroscopy; photochemistry; and photophysics.